Automatic Coregistration of High-Resolution MALDI-MSI and Raman Imaging Applied to Cardiac Tissue of Fabry Disease Mouse Models

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  Analytical Chemistry, https://doi.org/10.1021/acs.analchem.5c07622 
Dr. Johann Dierks  et al.

Points

German researchers successfully engineered a multimodal imaging framework that merges Raman spectroscopy and AP-MALDI mass spectrometry to map low-molecular-weight biomolecules on a single tissue section.
This novel system aligns chemical and structural datasets with a micrometer-level precision of approximately five micrometers to provide a highly detailed view of pathological changes.
Evaluating cardiac tissues from Fabry disease mouse models using the coregistered platform revealed highly heterogeneous accumulation patterns of toxic globotriaosylceramide lipoforms within the myocardium.
Microscopic analysis resolved that these damaging lipid species do not distribute evenly but instead aggregate into minute, highly localized, and chemically distinct cellular reservoirs.
Future clinical translations of this label-free molecular mapping technique could dramatically improve early sub-cellular diagnostics for patients suffering from rare genetic metabolic disorders.

Summary

Developed to map sub-microscopic molecular variations in genetic metabolic disorders, this study established a label-free multimodal imaging system to visualize tissue-level biomolecules. Characterizing low-molecular-weight compounds ( < 2000 Da) in thick organ structures remains a diagnostic hurdle because conventional histological stainings fail to localize precise lipid lipoforms. The research sought to overcome these limitations by integrating high-resolution vibrational spectroscopy with mass spectrometry imaging, creating an automated platform capable of mapping disease-relevant molecular changes before they manifest as gross anatomical pathologies under a microscope.

Investigators validated this system by combining Raman microscopy with atmospheric pressure matrix-assisted laser desorption/ionization mass spectrometry imaging (AP-MALDI-MSI). This dual-modality configuration leveraged Raman spectroscopy to isolate biochemical signatures of tissue structures with a 2 pixel resolution while utilizing AP-MALDI-MSI to identify specific analytes with a 5 lateral resolution. A newly developed spatial alignment algorithm successfully coregistered the two distinct datasets on the same tissue section with a micrometer-level precision of (5.1+1.6), allowing for high-resolution overlay maps.

Applying this platform to cardiac tissue from Fabry disease mouse models—including A (GLA) knockouts and transgenic cohorts overexpressing globotriaosylceramide (Gb3) synthase—revealed marked heterogeneity in lipid accumulation. The co-registered molecular maps showed that Gb3 does not accumulate uniformly; instead, distinct chemical lipoforms organize into highly localized, micrometric reservoirs throughout the myocardium. These findings suggest that co-registered Raman and AP-MALDI-MSI mapping represents a highly viable analytical strategy to assess interindividual metabolic heterogeneity and identify sub-cellular pathological deviations in patients with rare storage disorders.

Link to the article: https://pubs.acs.org/doi/10.1021/acs.analchem.5c07622

References 

Dierks, J., Brockmann, E. U., Arias-Loza, A.-P., Bocklitz, T., Nordbeck, P., Lorenz, K., Tolstik, E., & Heiles, S. (2026). Automatic coregistration of high-resolution maldi-msi and raman imaging applied to cardiac tissue of fabry disease mouse models. Analytical Chemistry, acs.analchem.5c07622. https://doi.org/10.1021/acs.analchem.5c07622